Skip to content
Sat Kartar Life logo

Sat Kartar Life

SATKARTAR NSE
₹134.90 up 4.55 (3.49%)
Market Cap
₹213 Cr

Sat Kartar Life (SATKARTAR) share price was ₹130.35 at the 28 Oct 2026 close; market capitalisation ₹206 Cr; sector Healthcare. The share price fell 29.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹105 Cr, against ₹87 Cr a year earlier and net profit was ₹9 Cr, against ₹6 Cr a year earlier (compared with Mar 2025). Promoters held 63.49% of Sat Kartar Life in Sep 2026, down 0.13 percentage points from Mar 2026. Its Tapetide Score is 57/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹130.35 −49.55 −27.54% 1Y

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹213 Cr
EBITDA
₹27.10 Cr
Return on Equity
25.3%
Debt to Equity
0.03
Book Value
₹43.34
EPS (TTM)
—
52W High
₹219.80
52W Low
₹110.30

Price-based figures as of 29 Oct 2026, 09:37 IST · TTM

Peer Comparison

Healthcare › Pharmaceuticals

₹1,766.5035.044,23,843 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
₹9,635.0087.452,55,779 Cr15.260.32%15.32%18.96%11,682 Cr2,925 Cr
₹4,598.4072.191,74,908 Cr9.520.82%12.16%9.06%17,058 Cr2,156 Cr
₹2,184.70107.941,18,042 Cr22.270.09%16.38%19.67%7,323 Cr1,090 Cr
₹1,180.5026.271,17,755 Cr4.340.09%16.99%19.24%28,515 Cr4,593 Cr
₹1,341.0034.731,11,931 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
₹1,370.5032.831,10,717 Cr3.130.96%11.21%14.88%28,589 Cr3,356 Cr
Sat Kartar Life (this company)
₹134.90—213 Cr3.110.52%25.30%34.31%——
Median 8 companies₹1,568.5035.041,17,899 Cr4.710.57%14.56%18.45%28,515 Cr3,184 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

57 Good
Overall score

Data confidence 81/100

Category scores

Quality Strong 74
Returns, margins, earnings quality 22% weight
Valuation Weak 42
Cheap vs sector & own history 24% weight
Growth Good 64
Sales & profit trajectory 9% weight
Financial Health Strong 84
Solvency, leverage, coverage 9% weight
Momentum Poor 20
Trend strength, vol-adjusted 12% weight
Ownership Average 49
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.0%

Weaknesses

1
  • Working capital days have increased from 28.3 days to 60.9 days

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
24.07% lower than 3Y

change over 1 year

Net Income Growth
74.49% lower than 3Y

change over 1 year

Cash Flow Change
109%

change over 1 year

EBITDA Margin Change
45.74%

change over 1 year Operating margin 14% · Mar 2026

Quarterly Results

Particulars Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
75
76
87
88
105
Expenses
69
70
79
78
91
Operating Profit
6
6
9
10
14
OPM %
8%
7%
10%
12%
14%
Other Income
0
0
1
2
1
Interest
0
0
0
0
0
Depreciation
1
1
1
1
2
PBT
5
5
8
11
13
Tax %
27%
25%
25%
26%
26%
Net Profit
4
4
6
8
9
EPS (₹)
3.32
3.3
3.8
4.95
6.01
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
52
83
128
163
194
Expenses
49
78
118
149
169
Operating Profit
3
5
10
14
25
OPM %
5%
6%
8%
9%
13%
Other Income
0
0
0
1
2
Interest
0
0
1
1
1
Depreciation
1
1
1
1
3
PBT
2
3
9
13
23
Tax %
7%
27%
27%
25%
26%
Net Profit
1
3
6
10
17
EPS (₹)
1.24
2.24
5.63
6.24
10.96
Div. Payout %
0%
0%
3%
11%
6%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.7
0.7
3
16
16
Reserves
0
3
7
36
52
Borrowings
8
4
2
6
2
Other Liabilities
3
8
11
7
14
Total Liabilities
12
15
22
65
84
Fixed Assets
5
4
8
6
11
CWIP
0
0
0
0
1
Investments
0
0
0
0
1
Other Assets
8
11
14
58
71
Total Assets
12
15
22
65
84
Figures in ₹ Crores

Cash Flow

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
7
-5
0
Investing
—
—
-3
0
-9
Financing
—
—
-3
34
-1
Net Cash Flow
—
—
2
28
-9
Free Cash Flow
—
—
7
-10
-7
CFO/EBITDA
—
—
98
-13
26
Figures in ₹ Crores

Ratios

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
1
0
7
13
26
Inventory Days
31
25
23
185
258
Days Payable
165
226
237
170
293
Cash Conversion Cycle
-134
-200
-208
29
-9
Working Capital Days
1
-14
-7
31
61
ROCE %
—
50%
98%
40%
36%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sat Kartar Life insights

59 extracted metrics + investor summaries across FY22–FY26.

Shareholding Pattern

FIIs0.77%Promot.63.49%DIIs1.86%Others8.08%Public25.79%As ofSep 2026

Documents

Frequently Asked Questions about Sat Kartar Life

What does Sat Kartar Life Ltd do?
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.[1]
Where is Sat Kartar Life Ltd (SATKARTAR) listed?
Sat Kartar Life Ltd trades as SATKARTAR on the NSE.
Which sector does Sat Kartar Life Ltd belong to?
Sat Kartar Life Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Sat Kartar Life Ltd?
Sat Kartar Life Ltd has a market capitalisation of ₹213.08 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Sat Kartar Life Ltd?
Over the last 52 weeks Sat Kartar Life Ltd has traded between ₹110.3 and ₹219.8 as of 29 Oct 2026.
Does Sat Kartar Life Ltd pay dividends?
Sat Kartar Life Ltd has a dividend yield of 0.54%.
What is the Return on Equity (ROE) of Sat Kartar Life Ltd?
Sat Kartar Life Ltd reported a return on equity of 25.30%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.[1]

Website satkartar.in
Listed 2025-01-17
Face Value ₹ 10
Shares Outstanding 1,57,95,276

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SATKARTAR.md for Sat Kartar Life Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More